Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
Target Oncol. 2017 Feb;12(1):19-35. doi: 10.1007/s11523-016-0463-4.ABSTRACTRenal…
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7535-E7544. doi:…
Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nat Commun. 2016 Nov 2;7:13467. doi: 10.1038/ncomms13467.NO ABSTRACTPMID:27804975…
Corrigendum: A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nat Commun. 2016 Nov 2;7:13467. doi: 10.1038/ncomms13467.NO ABSTRACTPMID:27804975…
Metformin targets histone acetylation in cancer-prone epithelial cells
Cell Cycle. 2016 Dec 16;15(24):3355-3361. doi: 10.1080/15384101.2016.1249547.…
STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
Cell Cycle. 2016 Dec 16;15(24):3413-3418. doi: 10.1080/15384101.2016.1245249.…
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer
Histol Histopathol. 2017 Jul;32(7):687-698. doi: 10.14670/HH-11-830.…
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Curr Pharm Des. 2016;22(46):6935-6945. doi: 10.2174/1381612822666160923115828.ABSTRACTOver…
Translational research in neuroendocrine tumors: pitfalls and opportunities
Oncogene. 2017 Apr 6;36(14):1899-1907. doi: 10.1038/onc.2016.316.…
Cancer network activity associated with therapeutic response and synergism
Genome Med. 2016 Aug 24;8(1):88. doi: 10.1186/s13073-016-0340-x.ABSTRACTBACKGROUND:…
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer
Gastroenterology. 2016 Nov;151(5):961-972. doi: 10.1053/j.gastro.2016.08.001.…
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Oncotarget. 2016 Sep 13;7(37):59766-59780. doi: 10.18632/oncotarget.11121.ABSTRACTThe…
